GBP2 and adenocarcinoma: Specifically, GBP2 and P2RX7 were significantly downregulated in both the “Adenomas and Adenocarcinomas” subtype and the “Cystic, Mucinous and Serous Neoplasms” subtype (p < 0.001) (Figure 2F), while SLC11A1 and HCLS1 were significantly upregulated in these two subtypes (p < 0.01) (Figure 2G).